Rayvio_News_Filter
$BIVI 🏥
BioVie announced Phase 2 ADDRESS-LC trial results for bezisterim showing statistically significant improvements versus placebo in fatigue, post-exertional malaise, and objective cognitive measures in Long COVID patients with higher baseline symptom burden.
Curated for market relevance
5
